Moderna 签署了一项为期四年的协议，向 17 个欧盟国家和盟友供应 mRNA COVID-19 疫苗。 Moderna signs a four-year deal to supply mRNA COVID-19 vaccines to 17 EU countries and allies.

Moderna 已获得向欧盟、挪威和北马其顿的 17 个国家供应其 mRNA COVID-19 疫苗的合同。 Moderna has secured a contract to supply its mRNA COVID-19 vaccine to 17 countries in the EU, Norway, and North Macedonia. 这项协议有效期最长为四年,包括保健服务提供者因其效率和安全而偏爱的预先填充的注射器。 The deal, valid for up to four years, includes prefilled syringes preferred by healthcare providers for their efficiency and safety. 已经授权对照最新变异剂使用的疫苗将加强欧盟的疫苗采购战略,并为大流行病的防备提供更多的选择。 The vaccine, already authorized for use against the latest variants, is set to enhance the EU's vaccine procurement strategy and provide more options for pandemic preparedness.